Enterprise Biotech Platform
Biotech & Drug Discovery
Accelerate therapeutic development with AI-powered compound discovery, genomic analysis, and preclinical intelligence
2.4M+
Compounds Screened
73%
Target Success Rate
12 weeks
Time to Lead
47
Active Programs
Full-Stack Discovery Platform
End-to-end capabilities from target identification to preclinical development
Compound Discovery
AI-powered molecular screening and lead optimization for novel therapeutics
Virtual screeningADMET predictionLead optimization
Genomic Analysis
Deep learning models for gene expression, variant analysis, and pathway discovery
RNA-seq analysisVariant callingPathway enrichment
Target Identification
Network biology and multi-omics integration for therapeutic target discovery
Protein interactionDisease mappingDruggability assessment
Preclinical Intelligence
Predictive models for toxicity, efficacy, and clinical trial optimization
Tox predictionPK/PD modelingTrial design
Production Validated
Real programs delivering real results across therapeutic areas
Neurotherapeutics
Psilocybin Analog Discovery
Identified 12 novel analogs with improved safety profiles using multi-objective optimization
3 candidates in preclinical development
Diagnostics
Mycotoxin Biosensor
Developed rapid detection platform for agricultural contamination screening
FDA breakthrough device designation
Nutraceuticals
Beta-Glucan Optimization
Enhanced immunomodulatory properties through strain engineering and fermentation optimization
4x potency increase achieved
Ready to Accelerate Your Discovery Pipeline?
Schedule a discovery call to discuss your therapeutic program and see how our platform can accelerate your timeline.